Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

81.83
+0.67000.83%
Volume:3.08M
Turnover:249.99M
Market Cap:48.04B
PE:11.66
High:81.84
Open:81.51
Low:80.35
Close:81.16
52wk High:83.00
52wk Low:64.01
Shares:587.10M
Float Shares:581.10M
Volume Ratio:0.63
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.02
EPS(LYR):6.98
ROE:15.53%
ROA:8.42%
PB:4.56
PE(LYR):11.72

Loading ...

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

Blockhead
·
Aug 22

Edwards Lifesciences Corp. Stock Climbs 3.1%, Outperforms Market

Dow Jones
·
Aug 21

Edwards Lifesciences Corp : Leerink Partners Raises Target Price to $85 From $84

THOMSON REUTERS
·
Aug 20

Edwards Lifesciences (EW) Receives a Buy from RBC Capital

TIPRANKS
·
Aug 20

Leerink Partners Adjusts PT on Edwards Lifesciences to $85 From $84, Maintains Market Perform Rating

MT Newswires Live
·
Aug 20

Edwards Lifesciences Enters Accelerated Share Repurchase Agreement

TIPRANKS
·
Aug 20

Edwards Lifesciences Executes $500 Million Stock Buyback Agreement

Reuters
·
Aug 20

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

THOMSON REUTERS
·
Aug 20

Larry L. Wood, Global President TAVR & Surg, Reports Disposal of Edwards Lifesciences Common Shares

Reuters
·
Aug 19

Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients

TIPRANKS
·
Aug 16

Edwards Lifesciences’ TRISCEND Study: A Game-Changer in Tricuspid Valve Replacement?

TIPRANKS
·
Aug 16

Kim Bolton’s Top Picks for August 13, 2025

Bloomberg
·
Aug 14

Argus Research Remains a Buy on Edwards Lifesciences (EW)

TIPRANKS
·
Aug 12

Gunnison Copper Announces Start-up of SX-EW Plant at Johnson Camp Mine

TIPRANKS
·
Aug 12

EW Scripps Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 11

Edwards Lifesciences Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
Aug 10

Hold Rating for Edwards Lifesciences Amid Uncertainty in JenaValve Deal and Adjusted EPS Guidance

TIPRANKS
·
Aug 08

Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment

TIPRANKS
·
Aug 08

Wells Fargo Reaffirms Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Aug 07

Edwards Lifesciences (EW) Receives a Hold from Robert W. Baird

TIPRANKS
·
Aug 07